First, the Rac1 inhibitor 1A-116 was used to treat kindlin-2-overexpressing A375 cells, and this treatment greatly reversed the effects of kindlin-2 overexpression on melanoma cell growth and metastasis. Here, FERMT2 is linked to melanoma.